Genetic Technology Alert. Developments in T Cell-Based Vaccine for Chlamydia; Direct Delivery of Zinc Finger Nucleases for Safe, Effective Gene Therapy

This issue profiles developments in T cell-based vaccine for chlamydia, validation studies with multi-biomarker test that enable improved clinical management of rheumatoid arthritis, and direct delivery of zinc finger nucleases for safe and effective gene therapy. Strategic partnership details and some important patents have also been included.